Vittorio Katis is a researcher at the Center of Medicines Discovery (CMD) at the University of Oxford, a multi-disciplinary Institute within the University of Oxford which focuses upon translational activities to catalyze the discovery of new medicines. Vittorio Katis supports the structural biology and assay development efforts of TREAT-AD, involved in advancing the development of small molecule probes for novel targets in Alzheimer’s disease.